Eli Lilly and : Exclusive Speaker Interview with Achim Kless, Pain Genetics Lead from Eli Lilly & Company Ahead of Pain Therapeutics
Pain Therapeutics Conference, Achim Kless, pain genetics lead, Eli Lilly and Co to find out about Achim’s work, vital topics being addressed in his presentation, thoughts on the most innovative therapy and on how the pain industry is responding to the opioid crisis and what the biggest growth area will be in 2021. The conference will convene on the 10th and 11th May 2021. £499 for pharmaceutical and biotechnology firms, and £999 for vendors and commercial firms at http://www.pain-therap...
Source: marketscreener.com